Jagsonpal Pharmaceuticals Ltd
JAGSNPHARM
Company Profile
Business description
Jagsonpal Pharmaceuticals Ltd is a pharmaceutical company. It develops and manufactures active pharmaceutical ingredients and formulations like Capsule and Tablet. The company operates in the Gynaecology, Orthopaedics, Dermatology and Paediatric segments. Its brands comprise Lycored, Maintane, Doxypal DR, and others.
Contact
3rd Floor, Phase - IV, Udyog Vihar
Plot No. 412-415, Nimai Tower
GurugramHR122015
INDT: +91 1244406710
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
1,410
Stocks News & Analysis
stocks
The ultimate investing hack: dividend growth stocks
Finding companies built for lasting dividend growth.
stocks
Is the data centre party over for Goodman?
Global spending spree on data centres could mean a declining return on invested capital.
stocks
Is AUB an opportunity after shares plunge 17%?
After a takeover bid was withdrawn shares dropped to below the pre-bid price.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,877.50 | 8.50 | -0.10% |
| CAC 40 | 8,074.61 | 22.39 | -0.28% |
| DAX 40 | 23,710.86 | 121.42 | 0.51% |
| Dow JONES (US) | 47,474.46 | 185.13 | 0.39% |
| FTSE 100 | 9,701.80 | 0.73 | -0.01% |
| HKSE | 26,095.05 | 61.79 | 0.24% |
| NASDAQ | 23,413.67 | 137.75 | 0.59% |
| Nikkei 225 | 49,303.45 | 0.17 | 0.00% |
| NZX 50 Index | 13,468.13 | 34.64 | -0.26% |
| S&P 500 | 6,829.37 | 16.74 | 0.25% |
| S&P/ASX 200 | 8,579.70 | 7.60 | -0.09% |
| SSE Composite Index | 3,897.71 | 16.29 | -0.42% |